James N Topper Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James N Topper.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James N Topper. James N Topper is Director in LA JOLLA PHARMACEUTICAL CO ($LJPC) and Director in ProNAi Therapeutics Inc ($DNAI) and Director in ANAPTYSBIO INC ($ANAB) and Director in Allena Pharmaceuticals, Inc. ($ALNA) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Aptinyx Inc. ($APTX) and Director in Entasis Therapeutics Holdings Inc. ($ETTX) and Director in Phathom Pharmaceuticals, Inc. ($PHAT) and Chief Executive Officer in Frazier Lifesciences Acquisition Corp ($FLAC).
Latest Insider Trading Transactions of James N Topper
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNA, ALPN, ANAB, APTX, ETTX, FLAC, LJPC, PHAT, SRRA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
| Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
| Dec 11 2020 | FLAC | Frazier Lifescienc ... | Topper James N | Chief Executive Off ... | Option Exercise | A | 11.50 | 333,333 | 3,833,330 | 333,333 | |
| Dec 11 2020 | FLAC | Frazier Lifescienc ... | Topper James N | Chief Executive Off ... | Option Exercise | A | 11.50 | 167,000 | 1,920,500 | 167,000 | |
| Dec 11 2020 | FLAC | Frazier Lifescienc ... | Topper James N | Chief Executive Off ... | Buy | P | 10.00 | 1,000,000 | 10,000,000 | 1,000,000 | 0 to 1000 K |
| Dec 11 2020 | FLAC | Frazier Lifescienc ... | Topper James N | Chief Executive Off ... | Grant | A | 10.00 | 501,000 | 5,010,000 | 501,000 | 0 to 501 K |
| Nov 18 2020 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Buy | J | 0.00 | 26,354 | 0 | 80,812 | 54.5 K to 80.8 K (+48.39 %) |
| Nov 18 2020 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Buy | J | 0.00 | 22,604 | 0 | 54,458 | 31.9 K to 54.5 K (+70.96 %) |
| Nov 18 2020 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Sell | J | 0.00 | 98,275 | 0 | 199,529 | 297.8 K to 199.5 K (-33.00 %) |
| Nov 18 2020 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Sell | J | 0.00 | 344,860 | 0 | 700,171 | 1 M to 700.2 K (-33.00 %) |
| Nov 18 2020 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Sell | J | 0.00 | 973,612 | 0 | 0 | 973.6 K to 0 (-100.00 %) |
| Nov 18 2020 | ALNA | Allena Pharmaceuti ... | Topper James N | Director | Option Exercise | A | 1.45 | 14,000 | 20,300 | 14,000 | |
| May 22 2020 | PHAT | Phathom Pharmaceut ... | Topper James N | Director | Option Exercise | A | 36.85 | 10,000 | 368,500 | 10,000 | |
| Apr 02 2020 | APTX | Aptinyx Inc. | Topper James N | Director | Grant | A | 2.16 | 4,976 | 10,748 | 3,195,055 | 3.2 M to 3.2 M (+0.16 %) |
| Jan 06 2020 | ALPN | ALPINE IMMUNE SCIE ... | Topper James N | Director | Option Exercise | A | 3.62 | 7,650 | 27,718 | 7,650 | |
| Jan 03 2020 | APTX | Aptinyx Inc. | Topper James N | Director | Option Exercise | A | 3.42 | 5,018 | 17,162 | 5,018 | |
| Oct 02 2019 | APTX | Aptinyx Inc. | Topper James N | Director | Option Exercise | A | 3.49 | 5,162 | 18,015 | 5,162 | |
| Jul 02 2019 | APTX | Aptinyx Inc. | Topper James N | Director | Option Exercise | A | 3.34 | 5,424 | 18,116 | 5,424 | |
| Jun 07 2019 | ALNA | Allena Pharmaceuti ... | Topper James N | Director | Option Exercise | A | 5.59 | 14,000 | 78,260 | 14,000 | |
| May 17 2019 | APTX | Aptinyx Inc. | Topper James N | Director | Option Exercise | A | 3.73 | 40,000 | 149,200 | 40,000 | |
| Feb 11 2019 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Option Exercise | A | 68.89 | 6,000 | 413,340 | 6,000 | |
| Jan 22 2019 | ALPN | ALPINE IMMUNE SCIE ... | Topper James N | Director | Option Exercise | P | 12.74 | 145,251 | 1,850,498 | 145,251 | |
| Jan 22 2019 | ALPN | ALPINE IMMUNE SCIE ... | Topper James N | Director | Buy | P | 5.37 | 372,439 | 1,999,997 | 2,571,450 | 2.2 M to 2.6 M (+16.94 %) |
| Jan 22 2019 | ETTX | Entasis Therapeuti ... | Topper James N | Director | Option Exercise | A | 5.66 | 15,000 | 84,900 | 15,000 | |
| Jan 04 2019 | ALPN | ALPINE IMMUNE SCIE ... | Topper James N | Director | Option Exercise | A | 4.09 | 7,650 | 31,289 | 7,650 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Topper James N | Director | Option Exercise | C | 0.00 | 6,651,574 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Topper James N | Director | Option Exercise | C | 0.00 | 5,212,833 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Topper James N | Director | Option Exercise | C | 0.00 | 7,000,000 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Topper James N | Director | Buy | P | 15.00 | 375,887 | 5,638,305 | 1,349,953 | 974.1 K to 1.3 M (+38.59 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Topper James N | Director | Buy | C | 0.00 | 320,898 | 0 | 974,066 | 653.2 K to 974.1 K (+49.13 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Topper James N | Director | Buy | C | 0.00 | 251,487 | 0 | 589,194 | 337.7 K to 589.2 K (+74.47 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Topper James N | Director | Buy | C | 0.00 | 337,707 | 0 | 337,707 | 0 to 337.7 K |
| Jun 26 2018 | APTX | Aptinyx Inc. | Topper James N | Director | Option Exercise | C | 0.00 | 21,946,301 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | Topper James N | Director | Option Exercise | C | 0.00 | 33,022,786 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | Topper James N | Director | Option Exercise | C | 0.00 | 28,895,188 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | Topper James N | Director | Buy | P | 16.00 | 150,000 | 2,400,000 | 3,190,079 | 3 M to 3.2 M (+4.93 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | Topper James N | Director | Buy | C | 0.00 | 795,553 | 0 | 3,040,079 | 2.2 M to 3 M (+35.44 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | Topper James N | Director | Buy | C | 0.00 | 1,197,076 | 0 | 2,244,526 | 1 M to 2.2 M (+114.28 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | Topper James N | Director | Buy | C | 0.00 | 1,047,450 | 0 | 1,047,450 | 0 to 1 M |
| Jun 12 2018 | ALNA | Allena Pharmaceuti ... | Topper James N | Director | Option Exercise | A | 13.52 | 10,182 | 137,661 | 10,182 | |
| May 15 2018 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Buy | J | 0.00 | 31,854 | 0 | 31,854 | 0 to 31.9 K |
| May 15 2018 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Sell | J | 0.00 | 301,024 | 0 | 0 | 301 K to 0 (-100.00 %) |
| May 15 2018 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Buy | J | 0.00 | 301,024 | 0 | 301,024 | 0 to 301 K |
| May 15 2018 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Sell | J | 0.00 | 1,372,000 | 0 | 973,612 | 2.3 M to 973.6 K (-58.49 %) |
| Feb 06 2018 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Option Exercise | A | 104.81 | 6,000 | 628,860 | 6,000 | |
| Jan 04 2018 | NVLS | ALPINE IMMUNE SCIE ... | Topper James N | Director | Option Exercise | A | 11.31 | 7,650 | 86,522 | 7,650 | |
| Nov 06 2017 | ALNA | Allena Pharmaceuti ... | Topper James N | Director | Option Exercise | C | 0.00 | 1,061,904 | 0 | 0 | |
| Nov 06 2017 | ALNA | Allena Pharmaceuti ... | Topper James N | Director | Option Exercise | C | 0.00 | 4,629,630 | 0 | 0 | |
| Nov 06 2017 | ALNA | Allena Pharmaceuti ... | Topper James N | Director | Option Exercise | C | 0.00 | 6,122,448 | 0 | 0 | |
| Nov 06 2017 | ALNA | Allena Pharmaceuti ... | Topper James N | Director | Buy | P | 14.00 | 500,000 | 7,000,000 | 3,330,373 | 2.8 M to 3.3 M (+17.67 %) |
| Nov 06 2017 | ALNA | Allena Pharmaceuti ... | Topper James N | Director | Buy | C | 0.00 | 254,409 | 0 | 2,830,373 | 2.6 M to 2.8 M (+9.88 %) |
| Nov 06 2017 | ALNA | Allena Pharmaceuti ... | Topper James N | Director | Buy | C | 0.00 | 1,109,159 | 0 | 2,575,964 | 1.5 M to 2.6 M (+75.62 %) |
| Nov 06 2017 | ALNA | Allena Pharmaceuti ... | Topper James N | Director | Buy | C | 0.00 | 1,466,805 | 0 | 1,466,805 | 0 to 1.5 M |
| Jul 26 2017 | NVLS | ALPINE IMMUNE SCIE ... | Topper James N | Director | Grant | A | 0.00 | 2,199,011 | 0 | 2,199,011 | 0 to 2.2 M |
| Feb 28 2017 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Option Exercise | A | 24.60 | 15,000 | 369,000 | 15,000 | |
| Feb 16 2017 | DNAI | Sierra Oncology, I ... | Topper James N | Director | Buy | P | 1.35 | 5,925,926 | 8,000,000 | 5,925,926 | 0 to 5.9 M |
| Jan 31 2017 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Option Exercise | C | 0.00 | 209,095 | 0 | 0 | |
| Jan 31 2017 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Option Exercise | C | 0.00 | 733,740 | 0 | 0 | |
| Jan 31 2017 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Option Exercise | C | 0.00 | 195,751 | 0 | 0 | |
| Jan 31 2017 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Option Exercise | C | 0.00 | 604,055 | 0 | 0 | |
| Jan 31 2017 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Option Exercise | C | 0.00 | 1,428,571 | 0 | 0 | |
| Jan 31 2017 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Buy | P | 15.00 | 88,709 | 1,330,635 | 297,804 | 209.1 K to 297.8 K (+42.43 %) |
| Jan 31 2017 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Buy | P | 15.00 | 311,291 | 4,669,365 | 1,045,031 | 733.7 K to 1 M (+42.43 %) |
| Jan 31 2017 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Buy | C | 0.00 | 209,095 | 0 | 209,095 | 0 to 209.1 K |
| Jan 31 2017 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Buy | C | 0.00 | 733,740 | 0 | 733,740 | 0 to 733.7 K |
| Jan 31 2017 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Buy | C | 0.00 | 2,228,377 | 0 | 2,228,377 | 0 to 2.2 M |
| Jun 20 2016 | DNAI | ProNAi Therapeutic ... | Topper James N | Director | Option Exercise | A | 2.06 | 38,835 | 80,000 | 38,835 | |
| Jul 21 2015 | DNAI | ProNAi Therapeutic ... | Topper James N | Director | Option Exercise | C | 0.00 | 1,869,606 | 0 | 0 | |
| Jul 21 2015 | DNAI | ProNAi Therapeutic ... | Topper James N | Director | Buy | P | 17.00 | 220,000 | 3,740,000 | 2,186,195 | 2 M to 2.2 M (+11.19 %) |
| Jul 21 2015 | DNAI | ProNAi Therapeutic ... | Topper James N | Director | Buy | J | 5.22 | 96,589 | 503,712 | 1,966,195 | 1.9 M to 2 M (+5.17 %) |
| Jul 21 2015 | DNAI | ProNAi Therapeutic ... | Topper James N | Director | Buy | C | 0.00 | 1,869,606 | 0 | 1,869,606 | 0 to 1.9 M |
| May 23 2008 | LJPC | LA JOLLA PHARMACEU ... | Topper James N | Director | Option Exercise | A | 1.82 | 10,000 | 18,200 | 10,000 | |
| May 24 2007 | LJPC | LA JOLLA PHARMACEU ... | Topper James N | Director | Option Exercise | A | 5.97 | 10,000 | 59,700 | 10,000 | |
| Apr 06 2007 | LJPC | LA JOLLA PHARMACEU ... | Topper James N | Director | Buy | P | 6.00 | 833,333 | 4,999,998 | 4,833,333 | 4 M to 4.8 M (+20.83 %) |
| May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | Topper James N | Director | Option Exercise | A | 3.99 | 8,000 | 31,920 | 8,000 | |
| May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | Topper James N | Director | Option Exercise | A | 3.99 | 2,000 | 7,980 | 2,000 | |
| Dec 14 2005 | LJPC | LA JOLLA PHARMACEU ... | Topper James N | Director | Option Exercise | P | 1.00 | 5,000,000 | 5,000,000 | 5,000,000 | |
| Dec 14 2005 | LJPC | LA JOLLA PHARMACEU ... | Topper James N | Director | Option Exercise | A | 0.69 | 40,000 | 27,600 | 40,000 | |
| Dec 14 2005 | LJPC | LA JOLLA PHARMACEU ... | Topper James N | Director | Buy | P | 0.75 | 20,000,000 | 15,000,000 | 20,000,000 | 0 to 20 M |
Page: 1